NeuroMetrix Inc (NURO) - Company Projected Revenue

Corporate company logo of NeuroMetrix, Inc. (NURO)

Limited adoption of neuromodulators is constraining the operating leverage of NeuroMetrix, Inc. (NURO) due to high costs, which is reflected in the firm's estimated sales volume on the GURU.Markets terminal linear chart, where the current metric equals 0.00. Growth is driven by partnerships with orthopedists to promote Quell systems, while profitability relies on the sale of wearable devices for diabetics and arthritis patients via online channels.

NeuroMetrix, Inc. - NURO Projected Sales Volume (period 07/04/2022 - 05/11/2025)

Summary analytical data breakdowns for NeuroMetrix Corporation (NURO)

- current price and projected stock value:
Summary company analytics:NeuroMetrix, Inc. NURO
Brand item of NeuroMetrix Corp

Projected revenue for NeuroMetrix, Inc. (NURO) reflects expected cash flow dynamics, forming the basis for assessing the business's fundamental value. This metric is calculated as the sum of future cash inflows, allowing investors to evaluate the company's recovery potential. Analyzing the company's future sales figures on the GURU.Markets platform reveals a current value of 0.00. The stability of this trend is supported by the defensive qualities of diabetic pain therapy, as consistent demand for medical devices ensures capital stability.

Key competitors

Company Future Sales Volume ISRG (Intuitive Surgical)|DHR (Danaher Corp) - Company Future Revenue|BD - Company Future Sales Volume|Projected Sales Volume STERIS Group STE|WST - Company Projected Revenue|Baxter International (BAX) - Company Future Sales Volume|Masimo Corp (MASI) - Company Projected Revenue|Company Future Sales Volume Stevanato Group|Company Projected Revenue Teleflex Incorporated|Company Expected Sales Volume Merit Medical Corp MMSI|Company Projected Revenue Envista (NVST)|ICU Medical - Company Revenue Forecast|DENTSPLY SIRONA Inc. - Company Future Sales Volume|Company Projected Revenue Volume LMAT (LeMaitre Vascular Inc)|ATRC - Company Projected Revenue|Company Future Sales STAAR Surgical Co STAA|NAGE: Projected Sales Volume|Company Expected Revenue ZIMV (ZimVie Inc.)|Company Projected Revenue AngioDynamics Corp|Company Expected Sales Volume Cerus Corp. CERS|Company Projected Revenue Teknova (TKNO)|Monogram Orthopedics Inc. - Company Revenue Forecast|Company Projected Revenue Sharps Technology, Inc. STSS|Projected Sales Volume InfuSystem Holdings INFU|UTMD: Company Future Sales Volume|Company Future Revenue KRMD (KORU Medical)|NYXH: Projected Sales Volume|MBOT (Microbot Medical, Inc) - Company Projected Revenue|Company Future Sales Volume PDEX|ZTEK: Company Future Revenue|Projected Sales Volume ELUT|Milestone Scientific Inc. - Company Revenue Forecast|Company Projected Revenue NEXGEL, Inc. NXGL|Retractable Tech - Company Projected Revenue|harvardbioscience.com - Projected Sales Volume|FEMY (Femasys Inc.) - Company Revenue Forecast|MHUA: Projected Sales Volume|Predictive Oncology Corp - Company Future Revenue|CJMB (Callan JMB) - Projected Sales Volume|Company Expected Sales Volume Atrion Corporation Inc. ATRI